·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÇÁ·¹½ºÆ¼Áö "À¯·´¼ Çã¼Áƾ ½Ã¹Ð·¯ Çã°¡ ºÎÁ¤ ÀÇ°ß Å뺸" ±â»çÀÔ·Â : 22.05.20 08:09:33 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=Á¤»õÀÓ ±âÀÚ] ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶´Â À¯·´ÀǾàǰû(EMA) »êÇÏ ¾à¹°»ç¿ëÀÚ¹®À§¿øȸ(CHMP)°¡ Áö³ 19ÀÏ(ÇöÁö½Ã°£) Çã¼Áƾ ¹ÙÀÌ¿À½Ã¹Ð·¯ 'HD201' Ç°¸ñÇã°¡¿¡ ´ëÇØ ºÎÁ¤Àû ÀÇ°ßÀ» Å뺸Çß´Ù°í 20ÀÏ °ø½ÃÇß´Ù. ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶´Â EMA¿¡ HD201 Ç°¸ñÇã°¡ Àç½É»ç¸¦ ½ÅûÇÒ ¿¹Á¤ÀÌ´Ù. ȸ»ç´Â "Çѱ¹°ú ij³ª´Ù¿¡ ±âÁ¦ÃâÇÑ HD201 Ç°¸ñÇã°¡½Åû °á°ú¸¦ ±â´Ù¸®°í ÀÖÀ¸¸ç, ÇâÈÄ ¹Ì±¹ ½ÄÇ°ÀǾ౹(FDA)¿¡µµ HD201 Ç°¸ñÇã°¡½Åû¼¸¦ Á¦ÃâÇÒ °Í"À̶ó°í ¹àÇû´Ù. X AD ±¤°í¸®ºä È®ÀÎÇØ º¸¼¼¿ä À̺¥Æ®Âü¿© ¡æ Á¤»õÀÓ ±âÀÚ(same@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ÇÁ·¹½ºÆ¼Áö '°ø¸ð¾× 5820¾ï'°¡Ä¡ Áõ¸í¡¦¸ÅÃâ º»°Ý... · ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶, ÃéÀå¾Ï ½Å¾à ÀüÀÓ»ó °á°ú ¹ßÇ¥ (ÁÖ)¹ÙÀ̳ؽº[¿À¼Û/¼Ûµµ]¾à»ç ¸ðÁý(ÆÄƮŸÀÓ °¡´É) ¹Ù·Î°¡±â ¾È°úÀÇ·á±â±â »ç¾÷ºÎ PDC (Practice Development Consultant) ¹Ù·Î°¡±â ¹Ì±¹ ±¡ º´¿ø ¾à»ç ¸ðÁý ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(4±Þ) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë Á¦Ç°±âȹ/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â Á¦Á¶°ü¸®¾à»ç ¸ðÁý(°æ·Â¹«°ü) ¹Ù·Î°¡±â [JW] °øÀå ¾à»ç ¼ö½Ãä¿ë(½ÃÈ, ÆòÅÃ, ´çÁø) ¹Ù·Î°¡±â [ÇÑÈÁ¦¾à] 3¿ù ¼ö½Ãä¿ë ¹Ù·Î°¡±â (ÁÖ) Ç»ÃÄÄÍ °³¹ßºÎ ÀÓ»ó °æ·ÂÁ÷ [ÄÚ½º´Ú »óÀå ±â¾÷] ¹Ù·Î°¡±â ûÁÖ µµ¸Å¾÷¼Ò ±Ù¹«¾à»ç ¹Ù·Î°¡±â º¹»ê³ªÀ̽º °ü¸®¾à»ç ±¸ÀÎ (¼öµµ±Ç¹°·ù¼¾ÅÍ) ¹Ù·Î°¡±â ¸ÞµðÄöóÀÌÅÍ(Medical Writer) ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇÁ·¹½ºÆ¼Áö À¯·´¼ Çã¼Áƾ ½Ã¹Ð·¯ Çã°¡ ºÎÁ¤ ÀÇ°ß Å뺸 URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÇÁ·¹½ºÆ¼Áö "À¯·´¼ Çã¼Áƾ ½Ã¹Ð·¯ Çã°¡ ºÎÁ¤ ÀÇ°ß Å뺸" ±â»çÀÔ·Â : 22.05.20 08:09:33 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=Á¤»õÀÓ ±âÀÚ] ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶´Â À¯·´ÀǾàǰû(EMA) »êÇÏ ¾à¹°»ç¿ëÀÚ¹®À§¿øȸ(CHMP)°¡ Áö³ 19ÀÏ(ÇöÁö½Ã°£) Çã¼Áƾ ¹ÙÀÌ¿À½Ã¹Ð·¯ 'HD201' Ç°¸ñÇã°¡¿¡ ´ëÇØ ºÎÁ¤Àû ÀÇ°ßÀ» Å뺸Çß´Ù°í 20ÀÏ °ø½ÃÇß´Ù. ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶´Â EMA¿¡ HD201 Ç°¸ñÇã°¡ Àç½É»ç¸¦ ½ÅûÇÒ ¿¹Á¤ÀÌ´Ù. ȸ»ç´Â "Çѱ¹°ú ij³ª´Ù¿¡ ±âÁ¦ÃâÇÑ HD201 Ç°¸ñÇã°¡½Åû °á°ú¸¦ ±â´Ù¸®°í ÀÖÀ¸¸ç, ÇâÈÄ ¹Ì±¹ ½ÄÇ°ÀǾ౹(FDA)¿¡µµ HD201 Ç°¸ñÇã°¡½Åû¼¸¦ Á¦ÃâÇÒ °Í"À̶ó°í ¹àÇû´Ù. X AD ±¤°í¸®ºä È®ÀÎÇØ º¸¼¼¿ä À̺¥Æ®Âü¿© ¡æ Á¤»õÀÓ ±âÀÚ(same@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ÇÁ·¹½ºÆ¼Áö '°ø¸ð¾× 5820¾ï'°¡Ä¡ Áõ¸í¡¦¸ÅÃâ º»°Ý... · ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶, ÃéÀå¾Ï ½Å¾à ÀüÀÓ»ó °á°ú ¹ßÇ¥ (ÁÖ)¹ÙÀ̳ؽº[¿À¼Û/¼Ûµµ]¾à»ç ¸ðÁý(ÆÄƮŸÀÓ °¡´É) ¹Ù·Î°¡±â ¾È°úÀÇ·á±â±â »ç¾÷ºÎ PDC (Practice Development Consultant) ¹Ù·Î°¡±â ¹Ì±¹ ±¡ º´¿ø ¾à»ç ¸ðÁý ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(4±Þ) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë Á¦Ç°±âȹ/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â Á¦Á¶°ü¸®¾à»ç ¸ðÁý(°æ·Â¹«°ü) ¹Ù·Î°¡±â [JW] °øÀå ¾à»ç ¼ö½Ãä¿ë(½ÃÈ, ÆòÅÃ, ´çÁø) ¹Ù·Î°¡±â [ÇÑÈÁ¦¾à] 3¿ù ¼ö½Ãä¿ë ¹Ù·Î°¡±â (ÁÖ) Ç»ÃÄÄÍ °³¹ßºÎ ÀÓ»ó °æ·ÂÁ÷ [ÄÚ½º´Ú »óÀå ±â¾÷] ¹Ù·Î°¡±â ûÁÖ µµ¸Å¾÷¼Ò ±Ù¹«¾à»ç ¹Ù·Î°¡±â º¹»ê³ªÀ̽º °ü¸®¾à»ç ±¸ÀÎ (¼öµµ±Ç¹°·ù¼¾ÅÍ) ¹Ù·Î°¡±â ¸ÞµðÄöóÀÌÅÍ(Medical Writer) ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇÁ·¹½ºÆ¼Áö À¯·´¼ Çã¼Áƾ ½Ã¹Ð·¯ Çã°¡ ºÎÁ¤ ÀÇ°ß Å뺸 URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÇÁ·¹½ºÆ¼Áö "À¯·´¼ Çã¼Áƾ ½Ã¹Ð·¯ Çã°¡ ºÎÁ¤ ÀÇ°ß Å뺸" ±â»çÀÔ·Â : 22.05.20 08:09:33 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=Á¤»õÀÓ ±âÀÚ] ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶´Â À¯·´ÀǾàǰû(EMA) »êÇÏ ¾à¹°»ç¿ëÀÚ¹®À§¿øȸ(CHMP)°¡ Áö³ 19ÀÏ(ÇöÁö½Ã°£) Çã¼Áƾ ¹ÙÀÌ¿À½Ã¹Ð·¯ 'HD201' Ç°¸ñÇã°¡¿¡ ´ëÇØ ºÎÁ¤Àû ÀÇ°ßÀ» Å뺸Çß´Ù°í 20ÀÏ °ø½ÃÇß´Ù. ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶´Â EMA¿¡ HD201 Ç°¸ñÇã°¡ Àç½É»ç¸¦ ½ÅûÇÒ ¿¹Á¤ÀÌ´Ù. ȸ»ç´Â "Çѱ¹°ú ij³ª´Ù¿¡ ±âÁ¦ÃâÇÑ HD201 Ç°¸ñÇã°¡½Åû °á°ú¸¦ ±â´Ù¸®°í ÀÖÀ¸¸ç, ÇâÈÄ ¹Ì±¹ ½ÄÇ°ÀǾ౹(FDA)¿¡µµ HD201 Ç°¸ñÇã°¡½Åû¼¸¦ Á¦ÃâÇÒ °Í"À̶ó°í ¹àÇû´Ù. X AD ±¤°í¸®ºä È®ÀÎÇØ º¸¼¼¿ä À̺¥Æ®Âü¿© ¡æ Á¤»õÀÓ ±âÀÚ(same@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°ü·Ã±â»ç · ÇÁ·¹½ºÆ¼Áö '°ø¸ð¾× 5820¾ï'°¡Ä¡ Áõ¸í¡¦¸ÅÃâ º»°Ý... · ÇÁ·¹½ºÆ¼Áö¹ÙÀÌ¿ÀÆĸ¶, ÃéÀå¾Ï ½Å¾à ÀüÀÓ»ó °á°ú ¹ßÇ¥
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇÁ·¹½ºÆ¼Áö À¯·´¼ Çã¼Áƾ ½Ã¹Ð·¯ Çã°¡ ºÎÁ¤ ÀÇ°ß Å뺸 URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö